FA
ORTX
Forefront Analytics’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-14,183
| Closed | -$110K | – | 71 |
|
|
2023
Q3 | $110K | Buy |
+14,183
| New | +$110K | 0.06% | 53 |
|
|
2023
Q2 | – | Sell |
-14,654
| Closed | -$78.7K | – | 78 |
|
|
2023
Q1 | $78.7K | Sell |
14,654
-150,240
| -91% | -$807K | 0.04% | 64 |
|
|
2022
Q4 | $61.2K | Buy |
164,894
+64,853
| +65% | +$24.1K | 0.03% | 66 |
|
|
2022
Q3 | $54K | Buy |
100,041
+7,400
| +8% | +$3.99K | 0.03% | 63 |
|
|
2022
Q2 | $58K | Sell |
92,641
-7,100
| -7% | -$4.45K | 0.03% | 61 |
|
|
2022
Q1 | $72K | Buy |
99,741
+47,175
| +90% | +$34.1K | 0.03% | 65 |
|
|
2021
Q4 | $70K | Buy |
52,566
+1,500
| +3% | +$2K | 0.02% | 60 |
|
|
2021
Q3 | $118K | Buy |
51,066
+33,775
| +195% | +$78K | 0.04% | 58 |
|
|
2021
Q2 | $75K | Buy |
17,291
+1,181
| +7% | +$5.12K | 0.03% | 64 |
|
|
2021
Q1 | $118K | Sell |
16,110
-15,980
| -50% | -$117K | 0.05% | 61 |
|
|
2020
Q4 | $139K | Buy |
32,090
+1,721
| +6% | +$7.46K | 0.06% | 55 |
|
|
2020
Q3 | $123K | Buy |
30,369
+11,239
| +59% | +$45.5K | 0.06% | 52 |
|
|
2020
Q2 | $115K | Buy |
+19,130
| New | +$115K | 0.07% | 51 |
|